Julien Capers
Patrimonio netto: 913 268 $ in data 31/10/2026
Patrimonio netto: 913 268 $ in data 31/10/2026
Julien E Capers worked as Corporate Counsel at CareDx, Inc., Associate General Counsel at Establishment Labs Holdings, Inc., and Assistant General Counsel at Zogenix, Inc. Education includes undergraduate studies at Stanford University and graduate studies at UC Davis School of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders 0,47% | 19/10/2026 | 787.300 ( 0,47% ) | 913 268 $ | 31/10/2026 |
| Società | Posizione | Fine |
|---|---|---|
| VERA THERAPEUTICS, INC. | Consigliere Generale | 01/01/2026 |
| CAREDX, INC. | Corporate Officer/Principal | - |
| ESTABLISHMENT LABS HOLDINGS INC. | Corporate Officer/Principal | - |
| ZOGENIX, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UC Davis School of Law
UC Davis School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Establishment Labs Holdings, Inc.
Establishment Labs Holdings, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures medical products | Health Technology |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale